Tianbo Jin

723 citations
48 papers · 522 indexed · h-index 15
Topics
RNA modifications and cancer (12 papers)Cancer-related molecular mechanisms research (9 papers)Epigenetics and DNA Methylation (7 papers)

In The Last Decade

Tianbo Jin

48 papers receiving 517 citations

Peers

Tianbo Jin
Comparison fields: 5 of 83
  • Molecular Biology 301
  • Cancer Research 137
  • Genetics 93
  • Oncology 77
  • Immunology 76
Replace Eleonora Adami with:
Eleonora Adami Singapore
Canan Cacına Türkiye
Michele Carrer United States
Javier Cotignola Argentina
Xiaoling Weng China
Marjolein H.F.M. Lentjes Netherlands
María Soledad Fernández‐García Spain
Vidalba Rocher-Ros United Kingdom
Alireza Heravi‐Moussavi Canada
Jonathan White United Kingdom
Tianbo Jin relative to Eleonora Adami Singapore Eleonora Adami's profile →
Citations per field
00.5×3.4×
Eleonora Adami · 1×
Citations per year

Countries citing papers authored by Tianbo Jin

Since Specialization
Citations

This map shows the geographic impact of Tianbo Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianbo Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianbo Jin more than expected).

Fields of papers citing papers by Tianbo Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianbo Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianbo Jin. The network helps show where Tianbo Jin may publish in the future.

Co-authorship network of co-authors of Tianbo Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Tianbo Jin. A scholar is included among the top collaborators of Tianbo Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianbo Jin. Tianbo Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 1
5 11
6 13
7 9
8 8
9 34
10
Polymorphisms of telomere-length related genes in three China ethnic groups.
1
11 44
12 10
13 15
14 30
15 7
16 15
17 22
18 23
19 25
20 8

About Tianbo Jin

Tianbo Jin is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 48 papers that have together received 522 indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (9 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Cancer Research (137 citations), Molecular Biology (301 citations) and Immunology (76 citations). Tianbo Jin has collaborated with scholars based in China, United States and United Arab Emirates. Frequent co-authors include Tingting Geng, Longli Kang, Mengdan Yan, Longli Kang, Fanglin Niu, Zhijun Dai, Xiaojie Xun, Xinghan Liu, Xi-Jing Wang and Kang Liu. Their work appears in journals such as Gene, Medicine and American Journal of Tropical Medicine and Hygiene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026